Image For Activity Cover
Better Bones: A Course on Osteoporosis and Metabolic Bone Disease
Course Description

As a supplemental course to the Endocrine Society’s Fellows Training Series (FTS), this course focuses on providing a comprehensive update on bone diseases, the basics and state-of-the-art diagnosis and treatment of osteoporosis, and the newest clinical guidelines for hypo- and hyperparathyroidism presented by renowned experts in the field. It is targeted to deliver comprehensive education on practical aspects of patient care through interactive and multi-faceted learning opportunities. This course series features 6 programs that will be released on a monthly basis providing free continuing medication education credit. You can take courses individually or the entire package dependent on your learning needs.

Featuring curated presentations, case questions, and learning resources, this course extends the educational reach by creating an interactive experience online for a broader audience. Each module will include:

  • Knowledge, skill, or perception questions
  • Clinical case vignettes
  • Answer comparisons
  • Additional practice resources
Learning Objectives

Upon successful completion of the activities, participants should be better able to:

  • Discuss the prevalence, pathophysiology, and progression of osteoporosis and other metabolic bone diseases.
  • Recognize and evaluate individuals at risk for bone fractures using appropriate imaging and diagnostic approaches and updated guidelines.
  • Discuss methods to Incorporate treatment strategies, including nutrition and exercise intervention, to reduce bone fragility and fracture risk in individuals with metabolic bone disease.
  • Devise individualized treatment strategies to manage osteoporosis and metabolic bone diseases that take into consideration predicted outcomes and limitations.
Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit:

The Endocrine Society designates each enduring activity module of this series for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC):

Successful completion each enduring activity module of this series, which includes participation in the evaluation component, enables the participant to earn up to 6.00 points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty and Disclosures
  • Marc Wein, MD, PhD - Back to Bone Basics: Fundamentals in Bone Health
  • Elaine W. Yu, MD - Patient Evaluation: Recognizing and Assessing Fracture Risk
  • Carolyn J. Crandall, MD, MS, FACP, Fellow of ASBMR, CCD - Treating Osteoporosis with Antiresorptives
  • Bente Langdahl, MD, PhD, DMSc - Osteoporosis: An Update on Sequential and Combination Therapy
  • Mary Bouxsein, PhD - Bone Biomechanics and Advanced Imaging
  • Michael Mannstadt, MD - Calcium Metabolism and the Parathyroids: Hyper- and Hypoparathyroidism

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following faculty reported  relevant financial relationships during the content development process for this activity: 

Marc Wein, M.D., Ph.D.Research Support, Radius Health, Inc., Galapagos NV.  Consulting Fees, Quench Bio, Galapagos NV

Elaine W. Yu, MD, MMSc: NIH Grants: NIDDK.  Research Grants: Amgen, Seres Therapeutics, Doris Duke Clinical Research Foundation.  UpToDate: Royalties for various Osteoporosis topics

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:  Beret Anne Casey, MD

The following SPC Committee members reported financial relationships:

Andjela T. Drincic, MDAdvisory Board Member, Corcept
Sergio Fazio, MD, PhDConsultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis
Angela M. Leung, MDSpeaker, Medical Education Resources, MCE Conferences, ATA Board Member
Amy Rothberg, MDSpouse, consultant of Merck
Katherine Araque, MDSpeaker, Novo Nordisk; Advisory Board, Corcept

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships: Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Kelly Lauter Roszko, MD, PhD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.


ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This educational activity is supported by an independent medical educational grant from Amgen, Inc.

Summary
Availability: On-Demand
Available Dec 07, 2020 to Dec 31, 2021
Cost: FREE
Credit Offered:
6 AMA PRA Category 1 Credits
6 ABIM-MOC Points
6 Participation Credits
Contains: 6 Courses
Recommended
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Powered By